GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a substantial shift in how we treat high blood sugar. These prescription therapies work by mimicking the body’s inherent GLP-1 process, which supports glucose regulation and lowers glucose release. Beyond glucose regulation, studies show that GLP-1 therapies may also provide cardiovascu